Alloderm (LifeCell Corp, USA) | 4% |
7%
| | 4% | 11% | 74% |
Tegaderm (3M Healthcare, UK) | | | | 4% |
85%
| 11% |
Apligraf (Organogenesis, USA; Navartis Pharmaceuticals Canada Inc, Canada) | 4% |
18%
|
0
| 5% | 5% | 68% |
Jelonet (Smith & Nephew, UK) | | | | 5% |
90%
| 5% |
Integra (Integra Lide Sciences Inc, USA) | 13% | 13% |
16%
|
27%
| 18% | 30% |
Promogran (Johnson and Johnson Medical Ltd, UK) | | |
0
| | 5% | 95% |
Duoderm (ConvaTec, UK) | 10% | 10% | | |
71%
| 9% |
E-Z Derm (Genetic Laboratories, USA) |
45%
| 5% | | | 20% | 30% |
Orcel (Ortec International Inc, USA) | 9% | |
0
| | 5% | 86% |
Oasis (Cook Spencer, USA) |
0
| | | | | 100% |
Mepitel (Molnlycke, UK) | 5% | | | |
86%
| 9% |
TransCyte (Advanced Tissue Sciences, USA) |
29%
|
36%
| | 14% | 5% | 16% |
B.G.C. Matrix (Brennen Medical Inc, USA) | | 14% |
5%
| 10% | 9% | 62% |
Kaltostat (ConvaTec, UK) | | | |
57%
| 38% | 5% |
Paratulle (SSL, UK) | | | | 5% |
90%
| 5% |
Biobrane (Dow B Hickam Inc, USA) |
19%
| 5% | 5% | 9% | 5% | 57% |
Chitosan | 4% | | |
14%
| 37% | 45% |